Hanny Al-Samkari, MD
@HannyAlSamkari
Followers
252
Following
19
Statuses
20
Classical hematologist, clinical investigator. Hemostasis, thrombosis, and hemolysis. Conquering blood diseases one study at a time!
Boston, MA
Joined December 2013
Names matter. Thrilled to share this Viewpoint we just published in @TheLancetHaem making the case that we should embrace the term "Classical Hematology" over "Benign" or Non-Malignant". Honored to have written this with Drs. Alison Loren and Alfred Lee!
1
23
91
RT @MGHCancerCenter: New @NEJM original article by Al-Samkari et al., "Mitapivat versus Placebo for Pyruvate Kinase Deficiency" https://t.c…
0
1
0
RT @MGHCancerCenter: Congratulations to #MGH Hematologists Hanny Al-Samkari, MD @HannyAlSamkari, David J. Kuter, MD, and Rebecca Karp Leaf,…
0
1
0
RT @MGHCancerCenter: #MGH researchers, including lead author @HannyAlSamkari, have published the results of a clinical trial that led the @…
0
1
0
Honored to share the results of ACTIVATE, the pivotal randomized phase 3 study leading to the FDA approval of mitapivat for pyruvate kinase deficiency, which we just published in the New England Journal of Medicine:
1
0
0
It's my pleasure to give a CDC Webinar on hereditary hemorrhagic telangiectasia with Dr. Raj Kasthuri on August 19! Check it out (and register) here!
0
1
6
RT @AnnalsofIM: Research led by @HannyAlSamkari and @DavidLeaf9 found that among critically ill adults with #COVID19, early therapeutic ant…
0
2
0
RT @_MiguelHernan: Critically ill #COVID19 patients have high risk of thromboembolism. While waiting for randomized trials of therapeutic…
0
13
0
RT @connors_md: Great work @LeivaOrly plus Richard Newcomb and @HannyAlSamkari sorry to loose you to cardiology😀
0
6
0
RT @RPTHjournal: How might we assess level of intervention for anemia in chronic bleeding disorders? A NEW letter to the editor at #RPTH s…
0
2
0
RT @RPTHjournal: How can we consider RBC transfusions & iron infusions as a single endpoint for studies of chronic bleeding disorders, like…
0
2
0
RT @NATFthrombosis: Check out a new episode of Clot Chronicles with @HannyAlSamkari. He discusses new research on #bleeding and #thrombosi…
0
3
0
RT @mtmdphd: COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection [Jul 23, 2020] @HannyAlSamkari et al.…
0
1
0
RT @pedrohlascasas: @isth presented us at #ISTH2020 a Late-Breaking Session on #COVID19 and related #VTE Lets summarize the findings: 1-@…
0
6
0
RT @MaryCushmanMD: Great talk #ISTH2020 from @HannyAlSamkari on rate of #VTE and potential impact of full anticoagulation in pts w #COVID19…
0
3
0
RT @svanwissen: Study by @HannyAlSamkari does not support emperic use of therapeutic #anticoagulation in critically ill patients with #Covi…
0
2
0
RT @kumar_riten: Ongoing excellent presentations at @isth 2020 meeting. Special shout out to @HannyAlSamkari who has 2 simultaneous pla…
0
1
0
RT @RPTHjournal: In a new study, 108 patients with #ITP had plasma C3, C4, and CH50 measured. ⬇️ levels were a common feature & were associ…
0
5
0
RT @RPTHjournal: Complement contributes to #platelet destruction in immune thrombocytopenia but is poorly characterized. A new #RPTH study…
0
2
0
Signed up for Twitter 8 years ago, and never once used it. January of 2021 and I'm tweeting for the first time. Well, better late than never!
0
0
1